参考文献/References:
[1].张柔,王颖. 急性心肌梗死治疗研究进展[J]. 实用中医内科杂志,2020,34(7):105-108.
[2].Safi M,Ahmed H,Al-Azab M,et al. PD-1/PDL-1 inhibitors and cardiotoxicity; molecular,etiological and management outlines[J]. J Adv Res,2021,29:45-54.
[3].Pegtel DM,Gould SJ. Exosomes[J]. Annu Rev Biochem,2019,88:487-514.
[4].Azizi M,Dianat-Moghadam H,Salehi R,et al. Interactions between tumor biology and targeted nanoplatforms for imaging applications[J]. Adv Funct Mater,2020,30(19):1910402.
[5].Adamiak M,Sahoo S. Exosomes in myocardial repair:advances and challenges in the development of next-generation therapeutics[J]. Mol Ther,2018,26(7):1635-1643.
[6].Cianciaruso C,Beltraminelli T,Duval F,et al. Molecular profiling and functional analysis of macrophage-derived tumor extracellular vesicles[J]. Cell Rep,2019,27(10):3062-3080.e11.
[7].Joo H,Suh JH,Lee HJ,et al. Current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent[J]. Int J Mol Sci,2020,21(3):727.
[8].Xunian Z,Kalluri R. Biology and therapeutic potential of mesenchymal stem cell-derived exosomes[J]. Cancer Sci,2020,111(9):3100-3110.
[9].Femminò S,Penna C,Margarita S,et al. Extracellular vesicles and cardiovascular system:biomarkers and cardioprotective effectors[J]. Vasc Pharmacol,2020,135:106790.
[10].Kir D,Schnettler E,Modi S,et al. Regulation of angiogenesis by microRNAs in cardiovascular diseases[J]. Angiogenesis,2018,21(4):699-710.
[11].Ma T,Chen Y,Chen Y,et al. MicroRNA-132,delivered by mesenchymal stem cell-derived exosomes,promote angiogenesis in myocardial infarction[J]. Stem cells int,2018,2018:3290372.
[12].Li SN,Li P,Liu WH,et al. Danhong injection enhances angiogenesis after myocardial infarction by activating MiR-126/ERK/VEGF pathway[J]. Biomed Pharmacother,2019,120:109538.
[13].Sun J,Shen H,Shao L,et al. HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis[J]. Stem cell res ther,2020,11(1):373.
[14].Zhu J,Lu K,Zhang N,et al. Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way[J]. Artif Cells Nanomed Biotechnol,2018,46(8):1659-1670.
[15].Olejarz W,Kubiak-Tomaszewska G,Chrzanowska A,et al. Exosomes in angiogenesis and anti-angiogenic therapy in cancers[J]. Int J Mol Sci,2020,21(16):5840.
[16].Peng Y,Zhao JL,Peng ZY,et al. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2[J]. Cell Death Dis,2020,11(5):317.
[17].Cai G,Cai G,Zhou H,et al. Mesenchymal stem cell-derived exosome miR-542-3p suppresses inflammation and prevents cerebral infarction[J]. Stem Cell Res Ther,2021,12(1):2.
[18].Ma Y,Mouton AJ,Lindsey ML,et al. Cardiac macrophage biology in the steady-state heart,the aging heart,and following myocardial infarction[J]. Transl Res,2018,191:15-28.
[19].Deng S,Zhou X,Ge Z,et al. Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization[J]. Int J Biochem Cell Biol,2019,114:105564.
[20].Xu R,Zhang F,Chai R,et al. Exosomes derived from pro-inflammatory bone marrow-derived mesenchymal stem cells reduce inflammation and myocardial injury via mediating macrophage polarization[J]. J Cell Mol Med,2019,23(11):7617-7631.
[21].Wu D,Zhang K,Hu P. The role of autophagy in acute myocardial infarction[J]. Front Pharmacol,2019,10:551.
[22].Zhang CS,Shao K,Liu CW,et al. Hypoxic preconditioning BMSCs-exosomes inhibit cardiomyocyte apoptosis after acute myocardial infarction by upregulating microRNA-24[J]. Eur Rev Med Pharmaco Sci,2019,23(15):6691-6699.
[23].Cheng H,Chang S,Xu R,et al. Hypoxia-challenged MSC-derived exosomes deliver miR-210 to attenuate post-infarction cardiac apoptosis[J]. Stem Cell Res Ther,2020,11(1):224.
[24].Sun XH,Wang X,Zhang Y,et al. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway[J]. Thromb Res,2019,177:23-32.
[25].Bailly AP,Perrin A,Serrano-Macia M,et al. The balance between mono- and NEDD8-chains controlled by NEDP1 upon DNA damage is a regulatory module of the HSP70 ATPase activity[J]. Cell Rep,2019,29(1):212-224.e8.
[26].Zou L,Ma X,Lin S,et al. Bone marrow mesenchymal stem cell-derived exosomes protect against myocardial infarction by promoting autophagy[J]. Exp Ther Med,2019,18(4):2574-2582.
[27].Li Y,Yang R,Guo B,et al. Exosomal miR-301 derived from mesenchymal stem cells protects myocardial infarction by inhibiting myocardial autophagy[J]. Biochem Biophys Res Commun,2019,514(1):323-328.
相似文献/References:
[1]宋菲,综述,俞梦越,等.干细胞来源的外泌体:心肌梗死治疗新启示[J].心血管病学进展,2016,(2):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
SONG Fei,YU Mengyue.Exosomes Derived from Stem Cells: Novel Approach in Treatment of
Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(4):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
[2]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(4):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[3]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(4):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[4]张伟 木胡牙提.外泌体源性miRNAs在心血管疾病中的研究进展[J].心血管病学进展,2020,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
Zhang Wei,Muhuyati.Exogenous miRNAs in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(4):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
[5]李一凡 张智伟.巨噬细胞相关的外泌体在心血管疾病中的作用研究进展[J].心血管病学进展,2020,(8):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
LI Yifan,ZHANG Zhiwei.Role of Macrophage-Related Exosomes in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(4):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
[6]叶莎 杨翠玲 郑媛媛.骨髓间充质干细胞来源外泌体通过PI3K/Akt途径减轻H2O2诱导心肌细胞损伤[J].心血管病学进展,2022,(3):269.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
YE Sha,YANG Cuiling,ZHENG Yuanyuan.Bone Marrow Mesenchymal Stem Cells Derived Exosomes Attenuate H 2O2 Induced Cardiomyocyte Injury Via PI3K/Akt Pathway[J].Advances in Cardiovascular Diseases,2022,(4):269.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[7]肖轶 余国龙.不同干细胞来源的外泌体在缺血性心脏病中的促血管新生作用[J].心血管病学进展,2022,(4):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
XIAO Yi,YU Guolong?/html>.Application of Exosomes Derived from Various Stem Cells?n Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(4):293.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.002]
[8]陈鹏莉 宋紫微 张曼玉 李丽丽.干细胞来源外泌体miRNA介导心脏修复的研究进展[J].心血管病学进展,2023,(7):636.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.014]
CHEN Pengli,SONG Ziwei,ZHANG Manyu,et al.Exosomal miRNA Derived from Stem Cells in Mediating Cardiac Repair[J].Advances in Cardiovascular Diseases,2023,(4):636.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.014]
[9]杨珂欣 李星辉 肖晨朦 姚晓涛 林萌 蔡佳.间充质干细胞来源外泌体改善心肌纤维化的研究进展[J].心血管病学进展,2022,(12):1123.[doi:10.16806/j.cnki.issn.1004-3934.20.10.015]
YANG Kexin LI Xinghui XIAO ChenmengYAO XiaotaoLIN MengCAI Jia.Improving Myocardial Fibrosis by Exosome Derived from Mesenchymal Stem Cell[J].Advances in Cardiovascular Diseases,2022,(4):1123.[doi:10.16806/j.cnki.issn.1004-3934.20.10.015]